Nuwellis Inc (NUWE)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $2.65M
Last updated: Nov 17, 2026 at 11:03 AM ET
Nuwellis Inc (NUWE) Financials: Revenue, Profit and Cash Flow
Nuwellis reported revenue of $8.27M for the fiscal year ended Dec 31, 2025, down 5.4% from the year before. That year, net income was -$17.52M with a net margin of -211.9%, operating cash flow was -$10.81M and free cash flow was -$10.90M. The quarter ended Sep 30, 2026 had revenue of $2.21M and net income of -$1.97M.
Revenue and Margins
Over the 9 years to Dec 2025, revenue grew from $1.29M, a compound annual rate of 22.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $8.27M | -5.4% | 62.0% | -134.3% | -211.9% |
| Dec 2024 | $8.74M | -1.4% | 64.9% | -125.7% | -127.7% |
| Dec 2023 | $8.86M | +3.8% | 56.2% | -198.9% | -228.0% |
| Dec 2022 | $8.54M | +7.9% | 55.7% | -201.0% | -170.0% |
| Dec 2021 | $7.92M | +6.5% | 56.7% | -246.5% | -246.9% |
| Dec 2020 | $7.44M | +35.0% | 54.5% | -228.8% | -212.8% |
| Dec 2019 | $5.51M | +10.3% | 51.7% | -328.5% | -328.7% |
| Dec 2018 | $5.00M | +40.7% | 26.6% | -340.9% | -340.8% |
| Dec 2017 | $3.55M | +175.6% | 22.2% | -416.9% | -376.6% |
| Dec 2016 | $1.29M | N/A | 44.7% | -1215.1% | -1225.1% |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.27M | $8.74M | $8.86M | $8.54M | $7.92M | $7.44M | $5.51M | $5.00M | $3.55M | $1.29M |
| Cost of revenue | $3.15M | $3.06M | $3.88M | $3.79M | $3.43M | $3.38M | $2.66M | $3.67M | $2.76M | $713.00K |
| Gross profit | $5.12M | $5.68M | $4.98M | $4.75M | $4.49M | $4.06M | $2.85M | $1.33M | $790.00K | $576.00K |
| Research and development | $2.71M | $3.21M | $5.42M | $4.34M | $4.98M | $3.67M | $4.67M | $3.05M | $1.48M | $8.11M |
| Operating income | -$11.11M | -$10.99M | -$17.63M | -$17.17M | -$19.53M | -$17.03M | -$18.11M | -$17.04M | -$14.81M | -$15.66M |
| Net income | -$17.52M | -$11.16M | -$20.21M | -$14.53M | -$19.55M | -$15.84M | -$18.11M | -$17.03M | -$13.38M | -$15.79M |
| EBITDA | -$6.55M | -$5.24M | -$16.36M | -$4.90M | -$19.06M | -$15.45M | -$17.87M | -$16.79M | -$12.61M | -$13.96M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.21M | $1.97M | $2.40M | $2.42M | $2.22M | $1.73M | $1.90M | $2.32M | $2.37M | $2.19M | $1.86M | $2.55M |
| Gross profit | $1.54M | $1.50M | $1.68M | $1.65M | $1.45M | $958.00K | $1.07M | $1.35M | $1.66M | $1.47M | $1.19M | $1.39M |
| Operating income | -$2.05M | -$3.17M | -$4.57M | -$2.44M | -$2.70M | -$2.91M | -$3.06M | -$2.39M | -$1.53M | -$2.32M | -$4.75M | -$3.59M |
| Net income | -$1.97M | -$4.83M | -$4.54M | -$2.42M | $468.00K | -$12.55M | -$3.01M | -$1.47M | $2.36M | -$7.72M | -$4.33M | -$5.51M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $261.00K by $824.00K.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $6.12M | $9.86M | $9.77M | $24.67M | $30.42M | $20.01M | $5.60M | $8.78M | $18.45M | $7.47M |
| Current assets | $5.19M | $8.86M | $8.21M | $22.77M | $28.13M | $18.54M | $4.04M | $8.13M | $17.86M | $2.42M |
| Cash and equivalents | $1.08M | $5.09M | $3.80M | $17.74M | $8.74M | $14.44M | $1.28M | $5.48M | $15.60M | $1.32M |
| Total liabilities | $3.49M | $3.33M | $6.56M | $12.32M | $4.47M | $3.69M | $3.61M | $2.84M | $2.22M | $5.23M |
| Short-term debt | $261.00K | $238.00K | $216.00K | $224.00K | $193.00K | $230.00K | $186.00K | N/A | N/A | N/A |
| Shareholder equity | $2.62M | $6.53M | $2.99M | $12.36M | $25.95M | $16.32M | $1.99M | $5.94M | $16.24M | $1.76M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $13.45M | $9.13M | $6.96M | $6.12M | $7.98M | $9.20M | $7.01M | $9.86M | $6.73M | $6.19M | $6.66M | $9.77M |
| Total liabilities | $3.59M | $11.17M | $4.29M | $3.49M | $4.07M | $18.16M | $3.42M | $3.33M | $3.55M | $13.02M | $5.78M | $6.56M |
| Cash and equivalents | $8.29M | $3.92M | $2.08M | $1.08M | $3.09M | $4.45M | $2.56M | $5.09M | $1.91M | $1.02M | $1.40M | $3.80M |
| Shareholder equity | $9.85M | -$2.06M | $2.66M | $2.62M | $3.91M | -$8.96M | $3.58M | $6.53M | $3.18M | -$6.84M | $885.00K | $3.21M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$10.81M | -$9.59M | -$17.94M | -$15.15M | -$17.84M | -$16.57M | -$16.37M | -$14.56M | -$11.92M | -$16.29M |
| Capital expenditures | $90.00K | $60.00K | $149.00K | $122.00K | $219.00K | $298.00K | $490.00K | $198.00K | $259.00K | $117.00K |
| Free cash flow | -$10.90M | -$9.65M | -$18.09M | -$15.27M | -$18.06M | -$16.87M | -$16.86M | -$14.76M | -$12.18M | -$16.41M |
| Dividends paid | N/A | $541.00K | $2.30M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing cash flow | -$90.00K | -$60.00K | $330.00K | $14.73M | -$15.72M | -$267.00K | -$490.00K | -$198.00K | -$259.00K | -$4.12M |
| Financing cash flow | $6.94M | $10.96M | $3.68M | $9.42M | $27.87M | $30.02M | $12.66M | $4.65M | $26.45M | -$1.36M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$2.98M | -$3.17M | -$3.11M | -$3.03M | -$3.15M | -$2.10M | -$2.54M | -$1.50M | -$2.47M | -$2.75M | -$2.86M | -$2.75M |
| Capital expenditures | $22.00K | $9.00K | $30.00K | $12.00K | $98.00K | $4.00K | $0 | $23.00K | $16.00K | $24.00K | $29.00K | $36.00K |
| Free cash flow | -$3.01M | -$3.18M | -$3.14M | -$3.04M | -$3.25M | -$2.10M | -$2.54M | -$1.53M | -$2.49M | -$2.78M | -$2.89M | -$2.79M |
Frequently Asked Questions About NUWE
What is Nuwellis' annual revenue?
Nuwellis reported revenue of $8.27M for the fiscal year ended Dec 31, 2025.
How fast is Nuwellis' revenue growing?
Revenue was down 5.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -1.1%.
Is Nuwellis profitable?
No. Nuwellis reported net income of -$17.52M for the fiscal year ended Dec 31, 2025, with a net margin of -211.9%.
How much free cash flow does NUWE generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$10.81M minus capital expenditures of $90.00K produced free cash flow of -$10.90M.
How much debt does Nuwellis have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $261.00K and cash and equivalents of $1.08M.
NUWE pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts